Elastography of the liver and beyond / Mirella Fraquelli, editor.
Fraquelli, Mirella, editor.
2021
RC847
Available Online

Linked e-resources

Linked Resource Online Access
Concurrent users Unlimited
Authorized users Authorized users
Document Delivery Supplied Can lend chapters, not whole ebooks

Details

Title Elastography of the liver and beyond / Mirella Fraquelli, editor.
ISBN 9783030741327 (electronic bk.)
303074132X (electronic bk.)
3030741311
9783030741310
DOI https://doi.org/10.1007/978-3-030-74132-7
Imprint Cham, Switzerland : Springer, 2021.
Language English
Description 1 online resource
Other Standard Identifiers 10.1007/978-3-030-74132-7 doi
Call Number RC847
Dewey Decimal Classification 616.3/620754
Summary This volume explores the main applications of elastographic techniques in hepatological and gastroenterological diseases, and elaborates on the use of these diagnostic techniques in a broad range of clinical settings; in this regard, it provides a clear critical methodological approach to the correct indication, taking into account the existing diagnostic pathways, the actual diagnostic accuracy of elastographic techniques, and their impact on clinical practice in terms of correct positioning of the test in the diagnostic pathway and clinical outcomes improvement. In the first chapters, which focus on the correct methodology for Diagnostic Accuracy Assessment of non -invasive techniques, the architecture of diagnostic research is discussed. In turn, the following sections describe a broad range of clinical applications in hepatology and gastroenterology. The closing section presents a number of case studies on practical issues, together with a critical discussion on how to promote the appropriate use of these technologies. Given its scope, the book will be of interest to specialists, post-graduate medical students, and researchers in the fields of hepatology and gastroenterology.
Bibliography, etc. Note References-6: Elastography in Liver-Transplanted Patients-6.1 Acute Rejection-6.2 Recurrent Hepatitis C-6.3 "Non-viral" Graft Disease After Transplantation-6.4 Non-alcoholic Fatty Liver Disease (NAFLD)-6.5 Elastography Outcome After Liver Transplantation-6.6 Spleen Stiffness and Liver Transplant-References-7: Elastography in Autoimmune Liver Diseases-7.1 Introduction-7.2 Primary Biliary Cholangitis-7.3 Primary Sclerosing Cholangitis-7.4 Autoimmune Hepatitis-7.5 Conclusions-References
Access Note Access limited to authorized users.
Source of Description Online resource; title from PDF title page (SpringerLink, viewed September 13, 2021).
Added Author Fraquelli, Mirella, editor.
Available in Other Form Elastography of the liver and beyond.
Linked Resources Online Access
Record Appears in Online Resources > Ebooks
All Resources
Intro
Foreword
Preface
Contents
Part I: Introduction to Elastography
1: Elastographic Measures: A Methodological Approach
1.1 Phase 0
1.2 Phase 1
1.3 Phase 2
1.4 Phase 3
1.5 Phase 4
1.6 Conclusions
References
2: Liver Stiffness: Thresholds of Health
2.1 Preamble: The Concept of Normality in Medicine
2.2 Healthy Ranges in Liver Disease Diagnostics
2.3 Definition of Healthy Ranges for Liver Stiffness
2.4 Conclusions
References
Part II: Liver Diseases

3: The Role of Transient Elastography for Fibrosis Staging in HCV-Related Chronic Liver Disease
3.1 Introduction
3.2 Assessment of Liver Disease Severity
3.2.1 Role of Liver Biopsy
3.2.2 Non-Invasive Assessment of Liver Fibrosis in CHC
3.3 Transient Elastography for the Assessment of Liver Fibrosis Prior to Antiviral Therapy
3.3.1 Combination Algorithms
3.3.2 TE vs. Other Elastography Techniques
3.4 Transient Elastography for the Assessment of Liver Fibrosis After SVR
3.5 Transient Elastography for Diagnosing Liver-Related Complications

3.5.1 Portal Hypertension
3.5.2 Gastro-Oesophageal Varices (GEV)
3.5.3 Hepatocellular Carcinoma (HCC)
3.6 Transient Elastography to Determine Prognosis
3.7 Conclusions
References
4: The Role of Elastography in HBV: Assessing Liver Fibrosis
4.1 Introduction
4.2 Liver Stiffness Cofactors and Confounders
4.3 TE in Untreated HBV Carriers
4.3.1 HBsAg Carriers Without Liver Disease
4.3.2 Untreated CHB Patients
4.4 TE in Treated CHB Patients
4.4.1 LS Kinetics During Antiviral Treatment

4.4.2 Correlation Between LS Changes During Treatment and CHB Outcomes
4.5 Conclusions
References
5: The Role of Transient Elastography in NAFLD
5.1 Fibrosis in NAFLD: The Burden
5.2 Transient Elastography: The Technique
5.2.1 The Procedure
5.2.2 Probes
5.2.3 The Role of Controlled Attenuation Parameter (CAP)
5.2.4 Limitations
5.3 Transient Elastography in NAFLD: The Quote
5.3.1 Diagnostic Accuracy
5.3.2 The Issue of Rule-In and Rule-Out
5.3.3 Confounding Factors
5.3.4 Liver Stiffness as Predictor of Liver Events
5.4 Conclusions

Browse Subjects

Show more subjects...

Statistics

from
to
Export